(Q49049683)

18 February 2018

title

Human kallikrein 6 as a biomarker of alzheimer's disease. (English)

1 reference

18 February 2018

0 references

0 references

Eleftherios P. Diamandis

1

1 reference

18 February 2018

author name string

Yousef GM

2

1 reference

18 February 2018

Petraki C

3

1 reference

18 February 2018

Soosaipillai AR

4

1 reference

18 February 2018

publication date

1 November 2000

1 reference

18 February 2018

published in

Clinical Biochemistry

1 reference

18 February 2018

volume

33

1 reference

18 February 2018

page(s)

663-667

1 reference

18 February 2018

issue

8

1 reference

18 February 2018

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

1 reference

Amyloid plaque core protein in Alzheimer disease and Down syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Tau protein and the neurofibrillary pathology of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Diagnostic accuracy of Alzheimer's disease: a clinicopathological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Clinical-neuropathological correlations in Alzheimer's disease and related dementias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Tau Protein in Cerebrospinal Fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Tau protein concentrations in cerebrospinal fluid of non-demented Parkinson's disease patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. HIV Neurobehavioral Research Center Group (HNRC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Increased CSF tau protein in corticobasal degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

A novel protease homolog differentially expressed in breast and ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2800%2900185-5

10.1016/S0009-9120(00)00185-5

7 January 2021

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

11166014

1 reference

18 February 2018